REGENXBIO steps closer to approval for Duchenne gene therapy
BioProcess International,
REGENXBIO announced positive interim safety and efficacy data from its Phase I/II AFFINITY DUCHENNE clinical trial for an…
The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID‐19 pandemic
Overview of attention for article published in Muscle & Nerve, May 2020
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (90th percentile)
-
High Attention Score compared to outputs of the same age and source (92nd percentile)
Readers on
- mendeley
- 373 Mendeley
